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ROS(TNF) is a cytokine that induces caspase-dependent (apoptotic) and caspase-
independent (necrosis-like) cell death in different cells. We used the murine ﬁbrosarcoma cell line model L929
and a stable L929 transfectant over-expressing a mutated dominant-negative form of BNIP3 lacking the C-
terminal transmembrane (TM) domain (L929-ΔTM-BNIP3) to test if TNF-induced cell death involved pro-
apoptotic Bcl2 protein BNIP3. Treatment of cells with TNF in the absence of actinomycin D caused a rapid fall in
the mitochondrial membrane potential (ΔΨm) and a prompt increase in reactive oxygen species (ROS)
production, which was signiﬁcantly less pronounced in L929-ΔTM-BNIP3. TNF did not cause the mitochondrial
release of apoptosis inducing factor (AIF) and Endonuclease G (Endo-G) but provoked the release of cytochrome
c, Smac/Diablo, and Omi/HtrA2 at similar levels in both L929 and in L929-ΔTM-BNIP3 cells. We observed TNF-
associated increase in the expression of BNIP3 in L929 that was mediated by nitric oxide and signiﬁcantly
inhibited by nitric oxide synthase inhibitor N5-(methylamidino)-L-ornithine acetate. In L929, lysosomal swelling
and activation were markedly increased as compared to L929-ΔTM-BNIP3 and could be inhibited by treatment
with inhibitors to vacuolar H+-ATPase and cathepsins −B/−L. Together, these data indicate that TNF-induced cell
death involves BNIP3, ROS production, and activation of the lysosomal death pathway.
© 2009 Elsevier B.V. All rights reserved.1. IntroductionApoptosis and necrosis are two classical forms of cell death but a
mixed death mode that shares elements of both characteristics may
also occur. In multicellular organisms, apoptosis can be triggered by
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l rights reserved.eliminate damaged or undesirable cell [1–3]. By contrast, necrosis is a
largely uncontrolled cell death and can result from exposure to
extremely noxious stimuli [4]. Apoptosis and necrosis are distin-
guished by morphological and biochemical criteria. Morphological
characteristics of apoptosis include condensed, fragmented cell nuclei,
a reduction in cell volume and cell membrane blebbing. Typical
morphological characteristics of necrosis include pronounced swel-
ling of the mitochondria and cell membrane, which leads to cell
rupture. Biochemical characteristics unique to apoptosis include an
increase in outer-mitochondrial membrane permeability, inter-
nucleosomal fragmentation of chromosomal DNA, and exposure of
phosphatidylserine on the outer surface of the cell [3,5].
Originally identiﬁed as a factor causing hemorrhagic necrosis in
established tumors [6,7], the cytokine tumor necrosis factor alpha
(TNF) has since been shown to play a crucial role in the pathogenesis
of acute and chronic inﬂammatory diseases [8,9]. TNF can induce
apoptotic (caspase-dependent) or necrotic (caspase-independent) cell
death in vitro, depending on the cell type used [10–12]. Inﬂammatory
responses include components of both TNF-induced apoptosis and
necrosis but in the presence of the pan-caspase/apoptosis inhibitor
and enhancer of necrosis, zVAD shows increased TNF toxicity in vivo
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surface TNF receptors known as high afﬁnity TNF-R1 (55 kD) and low
afﬁnity TNF-R2 (75 kD) [14]. TNF binding to its receptors activate a
cascade of biochemical reactions including caspase activation, activa-
tion of protein kinases [15], and the generation of ROS [16].
Upon binding to its high-afﬁnity receptor, TNF-family members
trigger a cascade of events, which lead to the recruitment of adaptor
proteins and the activation of caspase-8. The binding of CD95 to its
receptor activates caspase-8. Activated caspase-8 starts a mitochon-
dria-independent caspase cascade directly relaying on the activation
of caspase-3. Caspase-8 may also cleave and hyper-activate the pro-
apoptotic Bid molecule. Truncated bid (tBid) translocates to mito-
chondria and activates the mitochondrial death pathway [17,18].
Thus, mitochondria may serve as a signal ampliﬁer leading to the
activation of caspase-9, -6, -8 and -3 [19]. BNIP3 (Bcl2/E1B 19kD
interacting protein) over-expression induces an atypical, mixed
caspase-independent form of cell death. BNIP3 was discovered in a
yeast two-hybrid screen as the protein that interacts with adenovirus
E1B 19K, which is homologous to Bcl2 [20]. All Bcl2 family proteins
possess at least one of four Bcl2 homology domains (BH1 to BH4)
which determine the ability of these proteins to induce or inhibit
apoptosis [21]. BNIP3 belongs to the BH3-only subfamily and has a C-
terminal trans-membrane (TM) domain [22]. Over-expression of
BNIP3 leads to the opening of the mitochondrial permeability
transition pore (PTP), thereby abolishing the proton electrochemical
gradient. This activates a chain of events culminating in chromatin
condensation and DNA fragmentation [23,24]. Although chromatin
condensation is an established marker of apoptosis, it has been
proposed that BNIP3 induces a novel necrosis-like form of cell death.
BNIP3-induced cell death is independent of caspases and the nuclear
translocation of AIF, a mitochondrial ﬂavoprotein. Furthermore, the
release of cytochrome c from mitochondria is not involved in BNIP3-
mediated cell death [24]. Thus, BNIP3-mediated cell death resembles
TNF-induced cell demise that combines hallmarks of necrosis and
apoptosis, in L929 cells [12].
Here we report that TNF-triggered cell death induced in the
absence of actinomycin D (commonly used accelerator of TNF-induced
cell death) is partially inhibited by the dominant negative mutant of
BNIP3, L929-ΔTM-BNIP3, which lacks the C-terminal BNIP3 domain
essential for insertion of BNIP3 into the mitochondrial membrane and
execution of apoptotic function. TNF induced both a HIF-1α
independent but NO-dependent increase of BNIP3 expression, and
transfer of this Bcl2-familymember from the nucleus to mitochondria.
TNF-triggered cell death involved ROS-production and the activation
of the lysosomal pathway. The protective effect of ΔTM-BNIP3 was
associated with decreased mitochondrial ROS production.
2. Materials and methods
2.1. Reagents
Cell culture media were purchased from Sigma (Oakville, ON,
Canada) or Gibco (Canada). Phosphate buffered saline (PBS; pH=7.4),
N5-(methylamidino)-L-ornithine acetate salt (L-NMMA), 3-(4,5-
dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT),
and murine anti-human BNIP3 were from Sigma. Cell culture plastics
ware obtained from Nunc Co. (Canada). Anti-human/murine/rabbit
BNIP3, rabbit anti-human/murine/rat glyceraldehyde-3-phosphate
dehydrogenase (GAPDH), murine anti-human/murine/rat tubulin,
rabbit anti-human/murine/rat Omi/HtrA2, murine anti-human/
murine/rat cytochrome c, rabbit anti-human/murine/rat HIF-1α,
and goat anti-human/murine/rat Endo-G were obtained from Santa
Cruz Biotechnologies (USA). 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethyl-
benzimidazolylcarbocyanine iodide (JC-1), and DAF-2DA were
obtained from Invitrogen Molecular Probes (Canada). Murine anti-
human/murine cleaved caspase-3 (Asp175), was obtained from R&D,Canada. Rabbit anti-human/murine cleaved PARP-1 were purchased
from Cell Signaling, Canada. Caspase-Glo®-8, and -9 assay systems
were obtained from Promega, Canada.
2.2. Cell culture
Murine ﬁbroblast cell lines L929 and stable transfectant of L929
with a dominant negative mutant of BNIP3, L929-ΔTM-BNIP3, were
cultured in DMEM supplemented with 10% fetal calf serum, 100 U/ml
penicillin and 100 μg/ml streptomycin. Cells were incubated at 37 °C in
a humidiﬁed CO2 incubator with 5% CO2 and maintained under
logarithmic growth conditions.
2.3. Development of L929-ΔTM-BNIP3 cells
L929 cells were grown in 100 mm dishes. After reaching 80%
conﬂuence, cells were collected (106 cells) and transfected with
pCDNA3-BNIP3-ΔTM (5 μg) using electroporation. After 48 h trans-
fected cells were treated with selection media containing Geneticin
(G418) (1000 μg/ml) and kept in selection media for 3 months to
produce cells stably over-express ΔTM-BNIP3 protein. The expression
of ΔTM-BNIP3 protein was controlled by Western blot.
2.4. MTT cytotoxicity assay
Colorimetric MTT assay was employed to evaluate the cytotoxicity
effect of TNF on L929 and L929-ΔTM-BNIP3 cell lines [25]. Brieﬂy, cells
(1.5×104 cells/ml) were grown for 24 h in 96-well culture plates
containing 200 μl of culture medium. Deﬁned concentrations of TNF
were added and incubated for different time intervals, as shown in the
ﬁgures, followed by the incubationwith 3-(4,5-dimethyl-2-thiazolyl)-
2,5-diphenyl-2H-tetrazolium bromide. The percentage of cell viability
was calculated using the equation: [mean optical density (OD) of
treated cells /mean OD of control cells]×100.
2.5. Measurement of apoptosis by ﬂow cytometry
Apoptosis was measured using the Nicoletti method [26,27].
Brieﬂy, cells grown in 12 well plates were treated with S100A8/A9
(100 μg/ml) for the indicated time periods. After scrapping, cells were
pelleted by centrifugation at 800 g for 5 min, washed once with PBS,
and resuspended in hypotonic propidium iodide (PI) lysis buffer (1%
sodium citrate, 0.1% Triton X-100, 0.5 mg/ml RNase A, 40 μg/ml
propidium iodide). Cell nuclei were incubated for 30 min at 30 °C and
the nuclei were subsequently analyzed by ﬂow cytometry. Nuclei to
the left of the G1 peak containing hypo-diploid DNA were considered
to be apoptotic.
2.6. ROS measurement using ﬂow cytometry
L929 and L929-ΔTM-BNIP3 cells were treated with TNF with
indicated concentrations for different time points in 6 well plates.
Following treatment, cells were incubated in 1 μM dihydro-
rhodamine-123 (DHR-123; 1 μM) in DMSO (ﬁnal concentration 0.1%
v/v). Incubation with DHR-123 was for 30 min at 37 °C. To prevent
light accelerated oxidation, samples were maintained in the dark
prior to and during analysis. Fluorescence within dye-loaded cells
was analyzed by ﬂow cytometry (FACS Calibur; Becton Dickinson,
Mississauga, ON, Canada. For ﬂow cytometry, the excitation wave-
length for rhodamine-123 ﬂuorescence was 488 nm and emission at
530 nm (FL-1). Signals were processed using a logarithmic ampliﬁer
and ﬂuorescence distributions were plotted on a 4-decade logarith-
mic scale. 10,000 events were counted and, as a semi-quantitative
indicator for ROS levels, the geo-mean and mean-linear ﬂuorescence
values were calculated using Cell Quest Software (Becton Dickinson,
Mississauga, ON, Canada).
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To measure the Ψm of cells, the ﬂuorescent probe JC-1 (5,5,6,6 -
tetrachloro-1,1,3,3 -tetraethylbenzimidazole carbocyanide iodide) was
used. JC-1 exists as a monomer at low values of Ψm (green
ﬂuorescence), while it forms aggregates at highΨm (red ﬂuorescence).
Thus, mitochondria with normal Ψm concentrate JC-1 into aggregates
(red ﬂuorescence), but with de-energized or depolarized Ψm, JC-1
forms monomers (green ﬂuorescence). Brieﬂy, L929 and L929-ΔTM-
BNIP3 (5×105 cells/well were treated with TNF (0.2, 0.8 and 1 ng/ml)
for 8 and 12 h, washed in PBS (pH=7.4), and incubated for 15 min at
37 °C with 2.5 μg/ml JC-1. Cells were pelleted at 400 g for 5 min in
room temperature, washed in PBS, and analyzed by ﬂow cytometry.
The analyzer threshold was adjusted on the forward light scatter
channel to exclude most of the sub-cellular debris. When excited
simultaneously by a 488 nm argon-ion laser source, JC-1 monomers
and JC-1-aggregates were separated into the ﬂow cytometer FL1 and
FL2 channels, respectively. Mean ﬂuorescence intensity values for FL1
and FL2 expressed as relative linear ﬂuorescence channels were
obtained for at least 15,000 events in all experiments. The decrease in
Ψm was determined employing a 3-D plot with FL2, FL1, and cell
counts depicted on the x/y/z axis, respectively [28].
2.8. Cell fractionation
Cytosolic, mitochondrialand and nuclear fractions were generated
using a digitonin-based subcellular fractionation technique as
described previously [29,30]. Brieﬂy, 107 cells were harvested by
centrifugation at 800 g, washed in PBS pH 7.2, and re-pelletted. Cells
were digitonin-permeabilized for 5 min on ice at a density of 3×107/
ml in cytosolic extraction buffer (250mM sucrose, 70mMKCl,137mM
NaCl, 4.3mMNa2HPO4,1.4mMKH2PO4 pH 7.2,100 μMPMSF,10 μg/ml
leupeptin, 2 μg/ml aprotinin, containing 200 μg/ml digitonin). Plasma
membrane permeabilization of cells was conﬁrmed by staining in a
0.2% trypan blue solution. Cells were then centrifuged at 1000 g for
5 min at 4 °C. The supernatants (cytosolic and mitochondria fractions)
were saved and the pellets solubilized in the same volume of nuclear
lysis buffer, followed by pelletting at 12,500 g for 10 min at 4 °C. The
mitochondria was separated from cytosolic fraction pelletting
13,000 g and the pellets solubilized in equal amount of mitochondrial
lysis buffer (50mMTris pH 7.4,150mMNaCl, 2mMEDTA, 2mMEGTA,
0.2% Triton X-100, 0.3% NP-40, 100 μM PMSF, 10 μg/ml leupeptin, 2 μg/
ml aprotinin). For the detection of proteins, equal amount of fractions
protein were supplemented with 5× SDS-PAGE loading buffer,
subjected to standard 12% SDS-PAGE and transferred to nitrocellulose
membranes.
2.9. Immunoblotting
Upon treatment of cells with TNF (1 ng/ml) for indicated time
points, BNIP3, cytochrome c, and caspase-3 were detected by
immunoblotting in total cell lysates and fractionated cell compart-
ments, respectively. Brieﬂy, harvested cells were washed once with
cold PBS and cells were re-suspended for 20 min on ice in lysis buffer:
20 mM Tris–HCl (pH 7.5), 0.5% Nonidet P-40, 0.5 mM PMSF, and 0.5%
protease inhibitor cocktail (Sigma). Then, experimental procedures
were followed exactly as described previously [28].
2.10. Quantitative PCR measurement of BNIP3 mRNA
Cells were treated with TNF (1 ng/ml), TNF solvent (PBS) and
medium (control). Total cellular RNA was isolated using the RNeasy
Plus Mini Kit (Qiagen) according to the manufacturer's instructions.
1 μg of total RNA was reverse transcribed by using the QuantiTect
Reverse Transcription Kit (Qiagen) according to the manufacturer's
recommendations. mRNA expression of murine BNIP3 in L929 cellswas quantiﬁed on a Applied Biosystems 7500 Real-Time PCR System
instrument using Power SYBR Green PCR Master Mix (Applied
Biosystems) [31]. A dissociation curve was generated at the end of
each PCR cycle to verify that a single product was ampliﬁed. The
relative expression levels of the BNIP3 gene was calculated as fold
difference=2(−Ct), where Ct is threshold cycle normalized to 18S
internal control. Oligonucleotide primerswere as follows for BNIP3, 5′-
GCTCCCAGACACCACAAGAT-3′ (forward) and 5′-TGAGAGTAGCTG-
TGCGCTTC-3′ (reverse), and for 18S: 5′-CGCCGCTAGAGGTGAAATTC-
3′ (forward) and 5′-TTGGCAAATGCTTTCGCTC-3′ (reverse).
2.11. Nitric oxide measurement using DAF-2DA
Recently, a newﬂuorometricmethod based ondi-aminoﬂuorescein-
2 diacetate (DAF-2 DA) has been developed for the direct detection of
NO production. The DAF-2DA penetrates the cell membrane and is then
hydrolysed by cytosolic esterases, producing DAF which traps NO to
produce the green-ﬂuorescence signal ﬂuorescein. The high sensitivity
of DAF and its broad concentration response range make this system a
highly sensitive tool to detect even low amounts of NO produced by the
constitutive enzymes [32]. Brieﬂy, DAF-2DA stock solution was diluted
(2.5 μM) inpre-warmedHBSSbuffer (Hank's Balanced Salt solutionwith
20mMHepes bufferwithCa2+ andMg2+ (pH=7.4) and added to the cells
treated with TNF (0–24 h, 1 ng/ml) and control cells (treated with
medium and TNF solvent, PBS). The cells were incubatedwith DAF-2DA
for 40min and thenwashedwithHBSSone time to remove excess probe
and incubated in HBSS for more 30 min to allow complete de-
esteriﬁcation of the intracellular diacetates. Fluorescence excitation
and emission were calculated in 495 and 515 nm, respectively.
2.12. Immunocytochemistry and confocal imaging
Cells were grown overnight on coverslips and then treated with
TNF for 12 h. Cells were washed in PBS, ﬁxed in 4% paraformaldehyde
in PBS at room temperature, and permeabilized with 0.25% Triton X-
100 in PBS. To detect BNIP3, AIF, Endo-G, Omi/HtrA2, and Smac/Diablo
translocation, cells were incubated with anti-BNIP3 murine IgG
(Sigma; diluted 1:200) anti-AIF murine IgG (Santa Cruz Biotechnol-
ogy; diluted 1:500), anti-Endo-G rabbit IgG (Biovision, 1:50 dilution),
anti-Omi/HtrA2 rabbit IgG, and anti-Smac/Diablo rabbit IgG (Santa
Cruz Biotechnology; both at 1:150). Slides were washed three times
with PBS and incubated with Cy5-conjugated secondary antibody
(1:1000; BNIP3, AIF, and Endo-G) or FITC-conjugated secondary
antibody (1:50; BNIP3, Omi/HtrA2 and Smac/Diablo). To visualize
nuclei, cells were stained with DAPI (10 μg/ml). The mitochondria
were stained with Mitotracker Red CMXRos (Molecular Probes;
200 nM) in DMEM culture medium for 15 min prior to ﬁxation. The
cell-permeant MitoTracker probes contained a mildly thiol-reactive
chloromethyl moiety that appeared to be responsible for keeping the
dye associated with the mitochondria after ﬁxation. To label
mitochondria, cells were incubated with sub-micromolar concentra-
tions of a MitoTracker probe, which passively diffused across the
plasma membrane and accumulated in active mitochondria. Once the
mitochondriawere labeled, cells were treated with an aldehyde-based
ﬁxative to allow further processing of the sample. Because most of the
MitoTracker probes were retained after permeabilization with
detergents or organic solvents, the sample continued to exhibit the
ﬂuorescent staining pattern characteristic of live cells during
subsequent processing steps (e.g., immunocytochemistry, in situ
hybridization, or electron microscopy) [26]. Fluorescent images were
analyzed using an Olympus-IX81 multi-laser confocal microscope.
2.13. Caspase activity assays
Luminometric assays Caspase-Glo®-8, -9 (Promega, Canada, Nepean,
ON) were used to measure the proteolytic activity of Caspase-8 (IETD-
Fig. 1. TNF induced cell death in L929 cells. (A) L929 cells were treated with different
concentrations of TNF for 0–24 h and cell viability was assessed by MTT assay. For each
TNF concentration the treated cells were compared with control cells which had been
treated with the TNF solvent PBS. Results are expressed as percentage of corresponding
control and represent the means±SD of three independent experiments. TNF
signiﬁcantly induced cell death in L929 cells in different concentration and time points
(Pb0.001). (B) DNA histogram of L929 cells treated with TNF. The Nicoletti method was
used for sample processing, typical DNA-histogram s are shown. M2 (statistical marker)
has been placed to mark sub-diploid DNA. TNF- treatment (24 h, 1 ng/ml) induced
apoptosis only a fraction of cells. G1 and G2 peaks are clearly visualized and a sub-
diploid peak corresponding to apoptotic cells was clearly visible to the left from both
peaks that represent normal cells. (C) L929 cells were treated with TNF (1 ng/ml) for
indicated times, then total cell extracts were harvested, resolved by SDS-PAGE, and
cleaved PARP-1 was detected by Western blot. Protein loading was controlled with
GAPDH, (parallel experiment performed with the same protein extracts).
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manufactures instruction. Brieﬂy, cells cultured in 96-well plate (15000
cells/well), were treated with indicated concentrations of TNF for
different time points. The freshly prepared caspase reagents (100 μl per
well) contained either z-LETD-Luciferin alone or z-LEHD-Luciferin and
whole protein cell lysate extract buffer. For each experiment, negative
control cells (treated cells in medium without caspase reagent and
reagent blank containing medium only) were included. The measure-
ments were then performed exactly as described previously [28].
2.14. Statistical analysis
The results were expressed as means±SD and statistical differ-
ences were evaluated by one-way and two-way ANOVA followed by
Tukey's post-hoc test, using the software package SPSS 11.05 and
Graph Pad Prism 4.0, Pb0.05 was considered signiﬁcant.
3. Results
3.1. TNF induced cell death in L929 cells
L929 cells were treated with different concentrations of TNF in
different time points and TNF cytotoxic effect was measured using
MTTassay. In each concentration/time point cell viabilitywas accessed
comparing to corresponding control (cells treated with TNF solvent,
PBS). To avoid experimental artifacts, all experiments were performed
without the transcriptional inhibitor actinomycin D. Our results
showed that TNF induced signiﬁcant cell death in all concentration/
time point in L929 cells (Pb0.001) (Fig. 1A). To conﬁrm that the
observed form of cell death was apoptosis, the experiments were
independently repeated using an apoptosis-speciﬁc ﬂow cytometric
method (Nicoletti), which detects apoptosis-typical hypodiploid
nuclei. TNF-treated cells showed apoptotic cell death (Fig. 1B). It was
previously shown that TNF-induced apoptosis caused PARP-1 cleavage
[12]. In our experimental model we also show that TNF induced PARP-
1 cleavage in L929 cells, thus, providing additional conﬁrmation of
apoptosis induction by TNF (Fig. 1C).
3.2. TNF induced time and concentration-dependent BNIP3 expression in
L929 cells
We investigated the effect of TNF treatment on the regulation of
BNIP3 expression. Time-kinetics experiments indicate that BNIP3
protein expression (Fig. 2A, B) and BNIP3-mRNA content as assayed by
quantitative PCR (Fig. 2C), were increased in L929 cells treated with
TNF. BNIP3 protein expression also showed dependence on TNF
concentration. Thus, higher concentrations of TNF induced higher
expression of BNIP3 (Fig. 2D). Therefore for the further experiments
we have been mostly using the higher (1 ng/ml) TNF concentration.
3.3. Dominant-negative mutant of BNIP3 partially inhibited TNF toxicity
and TNF-induced BNIP3 mitochondrial translocation without affecting
cytochrome c release and caspase-9 activation
To study the role of BNIP3 in TNF cytotoxicity, we compared TNF-
triggered changes between L929 and a stable transfectants with the
dominant-negative mutant of BNIP3 that lacks the trans-membrane
domain, which is critical for its association with mitochondria (L929-
ΔTM-BNIP3). Due to the strong toxicity of BNIP3 even in transient
transfection experiments, we were unable to provide data on cells
even transiently overexpressing BNIP3. MTT assay revealed that L929-
ΔTM-BNIP3 cells were signiﬁcantly more resistant towards TNF as
compared to the parental L929 cell line (Pb0.01) (Fig. 3A). To avoid
experimental artifacts, all experiments were performed without the
transcriptional inhibitor actinomycin D. During the initiation of cell
death BNIP3 can associate with mitochondria and interact with Bcl2
Fig. 2. TNF induced time and concentration dependent BNIP3 expression in L929 cells. (A) Western blot detection of BNIP3 expression in L929 cells treated with 1 ng/ml TNF for 0, 8,
16 and 24 h. Tubulinwas included as loading control. 30 and 60 kD signals of BNIP3were signiﬁcantly increased after 8 and 16 h. In control samples “C”, the cells were treatedwith the
TNF solvent PBS. The Western blot signals are representative of three independent experiments. (B) Quantiﬁcation of BNIP3 expression in TNF treated. Western blots of experiments
performed as described in (A) were quantiﬁed as indicated in the method section (C) TNF induced an increase in BNIP3 mRNA expression. L929 cells were treated with TNF for
indicated times and BNIP3 mRNA was measured using qPCR. TNF induced a signiﬁcant increase in BNIP3 mRNA (Pb0.05). The data represent triplicates of three independent
experiments. (D) Western blot of BNIP3 expression in L929 cells treated with 0.75 and 1 ng/ml TNF for 12 h. BNIP3 expression was TNF-concentration dependent. Tubulin was
included as loading control. The Western blot data is representative for of three independent experiments.
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21.5 kD. However, in SDS-PAGE it migrates as a monomer of 30 kD and
a homodimer of ∼60 kD. In some models, homodimerization appears
to be a feature of mitochondrial localization [24] and TM-domain
mutants of BNIP3 including BNIP3Δ179–185 and point mutations at
L179 and G180 fail to homodimerize, as does a C-terminal deletion
mutant (BNIP3Δ184–194) [34]. Furthermore, exclusive mitochondrial
localization for BNIP3 was only shown for some tissues (i.e. muscle),
but not for others (i.e. the brain) [24]. Interestingly, the BH3 domain of
BNIP3 does not appear to be essential for BNIP3-dependent cell death
induction [34]. We have investigated the intracellular BNIP3 distribu-
tion upon TNF treatment in L929 and L929-ΔTM-BNIP3 cells. In
untreated L929 cells, BNIP3 was mainly localized in nuclei (Fig. 3B),
whereas in L929-ΔTM-BNIP3 cells negligible amounts of nuclear
BNIP3 were observed (Fig. 3B). In both L929 and L929-ΔTM-BNIP3
cells, TNF-treatment resulted in an increased presence of BNIP3 in the
mitochondrial fraction, while BNIP3 content decreased in the nuclear
fraction in L929 (Fig. 3B). The data obtained by cell fractionation were
conﬁrmed by immunohistochemistry followed by confocal micro-
scopy (Fig. 3C, D).
TNF-induced apoptosis and necrosis both involve mitochondrial
participation. Interaction of TNF with its TNF receptor-1 ultimately
leads to the activation of caspase-8 as well as activation of the
mitochondrial, caspase-9 dependent death pathway. We investigated
caspase activation upon TNF treatment in L929 and L929-ΔTM-BNIP3
cells. TNF-triggered mitochondrial cytochrome c release, and the
activation of caspase-9. The release of cytochrome c from mitochon-
dria and the extent of caspase-9 were similar in L929 and L929-ΔTM-
BNIP3 (Fig. 3E, F). This indicated that the TNF-mediated activation of
the mitochondrial death pathway did not require the presence of
fully-functional BNIP3. Furthermore, similar levels of caspase-3
activation were detected in L929 and L929-ΔTM-BNIP3 cells (Fig.
3G), again indicating that the caspase cascade was not affected by
BNIP3 mutation.3.4. TNF-mediated increase in BNIP3 expression involves NO-synthase
We investigated the effect of TNF treatment on the regulation of
BNIP3 expression. BNIP3 protein expression (Fig. 2A, B) andmRNA (Fig.
2C), was increased in L929 cells treated with TNF. As HIF-1α is one of
the transcription factors regulating BNIP3 expression [24,34,35], we
investigated if HIF-1α played role in TNF-induced increase of BNIP3
expression. TNF failed to induce HIF-1α expression, thus excluding
HIF-1α transcriptional activity as a cause of the TNF-mediated BNIP3
upregulation (data not shown). It was shown recently that BNIP3
expression could be affected by nitric oxide [36,37]. Endogenously
produced or exogenously added NO activates the Bnip3 promoter and
induces expression of BNIP3 protein in RAW264.7 macrophages under
normoxic conditions [36]. TNF signiﬁcantly induces NO and NO2−
production in L929 cells (Pb0.01) (Fig. 4A). These cells express both
constitutive and a TNF-inducible nitric oxide synthase (NO-synthase)
[38,39]. Treatment with the competitive nitric oxide synthase (NOS)
inhibitor (L-NMMA) prior to TNF stimulation signiﬁcantly inhibited
TNF-induced cell death and upregulation of 30 kD BNIP3-expression
and cell death in L929 cells (Fig. 4B, C). In the presence of L-NMMA,
there was a signiﬁcant increase in 60 kD BNIP3 but 30 kD BNIP3
signiﬁcantly decreased (Pb0.05) (Fig. 4C, D). The NOS inhibitor
attenuated the overall increase of BNIP3 content in TNF-treated cells
and shifted the equilibrium towards the 60 kD BNIP3 form. We have
also investigated if L-NMMA could prevent BNIP3 translocation to
mitochondria. Cells were pre and then co-treated with L-NMMA and
TNF (1 ng/ml). L-NMMA could not prevent BNIP3 translocation to
mitochondria (data was not show).
3.5. Dominant-negative BNIP3 mutant protects from TNF-triggered
mitochondrial depolarization and ROS generation
The change in Ψm is a common cellular event during TNF-
induced cell death [40–42]. TNF treatment induced changes in Ψm
Fig. 3. The expression of BNIP3 dominant negative mutant ΔTM-BNIP3 partially protects L929 against TNF-induced cell death via prevention of BNIP3 translocation to mitochondria,
without signiﬁcantly affecting in cytochrome c release and caspase-9, and -3 activation. (A) Effect of TNF on L929 and L929-ΔTM-BNIP3 cells. Cells were treated with different
concentrations of TNF for 0–24 h and cell viability was assessed byMTT assay. For each TNF concentration the treated cells were compared with control cells which had been treated
with the TNF solvent PBS. Results are expressed as percentage of corresponding control and represent the means±SD of three independent experiments. There is signiﬁcant
difference between parental L929 and L929-ΔTM-BNIP3 cell in TNF cytotoxicity (Pb0.01). (B) TNF induced mitochondrial translocation of BNIP3. BNIP3 presence in mitochondrial,
and nuclear fractions of L929 and L929-ΔTM-BNIP3 cells treated with TNF (1 ng/ml). BNIP3 signals were detected by Western blot. BNIP3 was mainly located in the nucleus in L929
cells and translocated to mitochondria when cells were treated with TNF. In L929-ΔTM-BNIP3 cells, TNF induced less pronounced BNIP3 translocation to mitochondria. Protein
loading was controlled with HDAC1 (nuclear fraction), and HSP60 (mitochondrial fraction). The data is representative for three independent experiments. (C, D) Intracellular
localization of BNIP3 in (C) L929 and (D) L929-ΔTM-BNIP3 cells was determined by confocal microscopy. Cells were either left untreated or treated with TNF (1 ng/ml) for 12 h. Cells
were immunostained with an anti-BNIP3 antibody followed by a FITC conjugated secondary antibody (green), and DAPI (nuclear DNA counterstain, blue). TNF-treated cells showed
mitochondrial BNIP3 translocation which was less pronounced in L929-ΔTM-BNIP3 cells. The anti-BNIP3 antibodies used were unable to differentiate between wild type and
mutated BNIP3. The magniﬁcation was 1000×. Representative micrographs are shown for all samples. (E) Cytochrome c detection by Western blot in mitochondrial and cytosolic
fractions of L929 and L929-ΔTM-BNIP3 cells treated with TNF (1 ng/ml) for indicated time. Protein loading was controlled with GAPDH (cytosolic fraction) and HSP60 (mitochondrial
fraction). The data represent representative blots of three independent experiments. (F) Caspase-9 activity in L929 and L929-ΔTM-BNIP3 cells treated with TNF (1 ng/ml) was
measured by a Caspase-Glo® luminometric assay. The caspase activity is presented as “fold increase” in comparison to the control of each time point. The data represent triplicates of
three independent experiments. There was no signiﬁcant difference in caspase-9 activity between the two cell lines (PN0.05). (G) L929 and L929-ΔTM-BNIP3 cells were treated with
TNF (1 ng/ml) for indicated time periods, then total cell extracts were harvested, resolved by SDS-PAGE, and active subunits of caspase-3 were detected by Western blot. Protein
loading was controlled with GAPDH, (parallel experiment performed with the same protein extracts). GAPDH represented for L929 cells. The data represent triplicates of three
independent experiments.
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5A). These changes were dose and time dependent (data not shown)
and revealed L929 that exhibited higher changes in Ψm than L929-
ΔTM-BNIP3 transfectants (Fig. 5A). Employing the ROS-sensitive
ﬂuorogenic marker DHR-123, we investigated ROS generation by
ﬂow cytometry in untreated and treated (TNF at 1 ng/ml) L929 and
L929-ΔTM-BNIP3 cells. When compared with wild type L929 cells,
L929-ΔTM-BNIP3 transfectants produced signiﬁcantly less ROS (Fig.
5B, C) (Pb0.05). N-acetycysteine (NAC) (a clinically-applied anti-
oxidant) interferes with increased ROS generation and TNF-induced
death in L929 cells [25]. In our experimental system, NAC pre- and
co-treatment partially prevented TNF-induced cell death in L929
cells (Fig. 5D).
3.6. TNF treatment does not induce EndoG and AIF release from
mitochondria in L929 cells
AIF is a phylogenetically conserved ﬂavoprotein essential for
apoptosis during embryonic development [43]. It is a redox-active
NADH-oxidase and, upon apoptosis induction, translocates from
mitochondria to the nucleus to induce chromatin condensation [44].Endo-G is a mitochondrial nuclease encoded by a nuclear gene.
Once released from mitochondria into the cytosol, Endo-G trans-
locates to the nucleus where it causes oligo-nucleosomal DNA
fragmentation even in the presence of caspase inhibitors [45]. In
mammalian cells, Endo-G cooperates with exonuclease and DNase-I
to facilitate DNA processing [46]. We did not observe the release of
these molecules from mitochondria upon TNF treatment (Fig. 6A, B).
Thus, AIF and Endo-G do not appear to be components of TNF-
triggered cell death pathway in L929 cells in our experimental
system. Similar data has also been observed for L929 ΔTM-BNIP3
(not shown).
3.7. TNF-triggered mitochondrial release of Smac/Diablo and Omi/HtrA2
is unaffected by ΔTM-BNIP3
To further examine the effect of TNF on mitochondria, we
monitored the TNF-triggered release of Smac/Diablo and Omi/HtrA2
from mitochondria. Murine Smac and its human ortholog Diablo are
proteolytically processed in mitochondria and released from the
intermembrane mitochondrial space upon triggering apoptosis [47].
The mammalian serine protease Omi, also known as high-
Fig. 4. TNF induces generation of reactive nitrogen species that are involved in TNF cytotoxicity and BNIP3 expression in L929 cells. (A) L929 cells were treated with TNF (1 ng/ml) for
indicated time and NO production was measured using DAF-2A. TNF induced a signiﬁcant increase in NO production (Pb0.05). The data represent triplicates of three independent
experiments. (B) NO-synthase inhibitor interfered with TNF-induced cell death. Pre-treatment of L929 cells for 1 h with L-NMMA (500, 2500, 5000 nM) reduced TNF cytotoxicity
(TNF: 1 ng/ml for 24 h) as measured byMTTassay. Data represent values from quadruplicates of four independent experiments (Pb0.05). Cells treated with TNF solvent PBS served as
control. (C) Western blot analysis of BNIP3 expression in L929 cells upon pre-treatment with L-NMMA (500 nM for 1 h), with treatment with 1 ng/ml TNF for indicated time (right
panel). Left panel, that represents the treatment with TNF alone served as a control. GAPDH was included as loading control. In each sets of data, cells treated with TNF solvent PBS
and L-NMMA (500 nM and pre-treated for 1 h) served as an internal control “C”. (D) Quantiﬁcation of BNIP3 expression in TNF treated cells pretreated with L-NMMA. NO synthase
inhibitor shifted the 30 kD/60 kD BNIP3 ratio toward the 60 kD BNIP3 form, whereas total BNIP3 expression remained unchanged. Data were adjusted to the “C” control signal and
represent triplicates of three independent experiments.
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chondria to the cytosol during apoptosis where it contributes both
to caspase-dependent and caspase-independent apoptosis [48].
Both Smac/Diablo and Omi/HtrA2 bind and antagonize the actions
of inhibitors of apoptosis (IAPs) [49]. L929 cells were treated with
TNF (1 ng/ml, 12 h) and the subcellular location of Smac/Diablo and
Omi/HtrA2 was examined by confocal imaging (Fig. 6C, D).
Immunoreactive Smac/Diablo and Omi/HtrA2 were present in
mitochondria of cells treated with medium alone (Fig. 6C, D,
control panel). Upon TNF-treatment, these proteins were released
from the mitochondria to the cytosol (Fig. 6C, D) indicating that
these proteins are involved in TNF-induced cell death. Over-
expression of ΔTM-BNIP3 did not signiﬁcantly inhibit the TNF-
mediated release of Smac/Diablo and Omi/HtrA2 (Fig. 6C, D). This
might be explained by the TNF-induced increase in wild-type BNIP3
expression, which may compensate for the presence of dominant
negative mutant ΔTM-BNIP3.3.8. Dominant-negative BNIP3 mutant counteracts the activation of
lysosomal death pathway by TNF
Lysosomes are important organelles for the control of caspase-
independent cell death. In the event of cell death, lysosomal acid
hydrolases of the cathepsin (cath) family frequently translocate from
lysosomes into the cytosol. In some experimental systems cath-B and
cath-D are rate limiting for death induced by interferon-γ, TNF, p53, or
pro-oxidants [50]. The vacuolar H+-ATPase inhibitor baﬁlomycin A1
(Baf A1; 0.05 μM), the irreversible inhibitor of Cath-B and cath-L zFF-
fmk (100 μM), and the cath-B inhibitor CA-074-Me (10 μM), partially
inhibited TNF-induced cell death in L929 and L929-ΔTM-BNIP3 cells
(Fig. 7A–C) (Pb0.05). Staining of cells with the acidophilic lysosomal
probe LTR revealed that TNF caused an increase in lysosomal volume
in L929 cells (Fig. 7D), whichwas absent in L929-ΔTM-BNIP3 cells (Fig.
7E). Pre-treatment with baﬁlomycin A1, zFF-fmk, CA-074-Me, or
antioxidant N-acetyl-L-cysteine (5 mM) abolished the differences in
Fig. 5. The over-expression of dominant-negative form of BNIP3 decreased TNF-induced ROS production and Δψm. (A) ΔTM-BNIP3 over-expression partly protected from TNF-
triggered Δψm as shown by cytoﬂuorimetric analysis of ψm in L929 (upper panel) and a derivative that over-expresses ΔTM-BNIP3 (lower panel). Cells were treated for 12 h with
medium alone (left diagrams), or with TNF (1 ng/ml). TNF treatment triggered marked changes in mitochondrial membrane potential that were partially abolished in ΔTM-BNIP3
over-expressing cells. A representative experiment of four is shown. (B, C) In L929 (B) TNF (1 ng/ml) triggered marked ROS production, whereas in (C) L929-ΔTM-BNIP3 cells TNF
treatment elicited only minimal (∼4–15%) induction of ROS (Pb0.05). Cells were treated with TNF for the indicated time periods and ROS was measured using dihydrorhodamine-
123. Experiments were repeated four times and mean ROS values are shown. (D) Broad-spectrum anti-oxidant, NAC, partially inhibited TNF induced cell death. L929 cells were pre-
treated with indicated concentrations of NAC for 3 h and than co-treated with TNF (1 ng/ml) and indicated concentration of NAC for 24 h. NAC partially inhibited TNF induced cell
death (Pb0.05). The data represents triplicates of three independent experiments.
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response to TNF treatment (data not shown). Thus, the higher levels
of ROS observed in L929 as compared to L929-ΔTM-BNIP3 cells
appeared to contribute to lysosomal damage in TNF-treated L929 cells
and this may involve the release of cathepsins into the cytoplasm
[51,52].
4. Discussion
In the present study, we have investigated the role of the pro-
apoptotic Bcl2-family member BNIP3 in TNF-induced cell death. We
employed the rodent ﬁbrosarcoma cell line L929, which has been
widely used to study the mechanisms of TNF cytotoxicity. TNF induces
cell death in L929, which may resemble necrosis or apoptosis [50,53].
BNIP3 is a pro-death member of the Bcl2-family of apoptotic proteins
[54]. Its mechanism of action is not fully understood. It is accepted
that, at least in part, it exerts its activity by inserting into the
mitochondrial membrane. This leads to the opening of the mitochon-
drial permeability pore with resultant membrane depolarization andFig. 6. TNF did not affect themitochondrial release of caspase-independent apoptosis inducing
release of caspase-dependent apoptosis inducing proteins (Smac/DIABLO, Omi/HtrA2). (A, B
apoptoticmitochondrial proteins AIF and Endo-G from L929. Cellular localization of AIF (A) an
(1 ng/ml) for 12 h prior to immunostaining with anti-AIF and anti-Endo-G antibodies fol
counterstained with DAPI (blue) and mitotracker (red) to visualize nuclei and mitochondria
apoptotic mitochondrial proteins Omi/HtrA2 and Smac/Diablo in L929 and L929-ΔTM-BN
mitochondrial proteins Omi/HtrA2 and Smac/Diablo. Cellular localization of Omi/HtrA2 (
microscopy. Cells were treatedwith 1 ng/ml TNF for 12 h prior to immunostaining with anti-O
secondary antibody (green). Cells were counterstainedwith DAPI (blue) andmitotracker (red
1000×. Representative micrographs are shown for all samples.subsequent ROS generation [35]. This rapid and profound mitochon-
drial dysfunction does not involve the release of mitochondrial
cytochrome c, caspase activation, or the nuclear translocation of AIF
[24]. The resulting cell death is accompanied by an increase in plasma
membrane permeability [34]. To address the role of BNIP3 in TNF-
induced cell death, we employed wild-type BNIP3 and a deletion
mutant of BNIP3 which lacks the transmembrane domain (ΔTM-
BNIP3) known to be important in BNIP3-induced cell death [55]. TNF-
stimulated cell death in L929 was BNIP3-dependent and the presence
of ΔTM-BNIP3 resulted in signiﬁcantly higher TNF-resistance. BNIP3-
mediated cell death is independent of caspase activation and the
release of cytochrome c from mitochondria [24]. Likewise, caspase-3
and -9 activity and cytochrome c release were similar in the presence
of wild type BNIP3 and ΔTM-BNIP3 in L929. Thus, TNF triggered
caspase-independent cell death, which was partially inhibited by
ΔTM-BNIP3. Some Bcl2-like proteins contain a single C-terminal TM
helix to facilitate their membrane targeting [56]. Upon induction of
cell death, BNIP3 integrates into the mitochondrial outer membrane
with the N-terminus (residues 1–162) pointing into the cytoplasm andproteins (AIF, Endo-G) andΔTM-BNIP3 over-expression did not affect themitochondrial
) TNF-treatment (in the absence of actinomycin D) did not trigger the release of pro-
d Endo-G (B) were determined by confocal microscopy. L929 cells were treatedwith TNF
lowed by detection with Cy-5-conjugated secondary antibody (magenta). Cells were
. (C, D) TNF-treatment (in the absence of actinomycin D) triggered the release of pro-
IP3 cells. ΔTM-BNIP3 over-expression did not prevent the release of pro-apoptotic
C) and Smac/Diablo (D) in L929 and L929-ΔTM-BNIP3 cells was probed by confocal
mi/HtrA2 and anti-Smac/Diablo antibodies, followed by detectionwith FITC-conjugated
). In control experiments, cells were treatedwith TNF solvent PBS. Themagniﬁcationwas
Fig. 6 (continued).
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Fig. 7. ΔTM-BNIP3 over-expression counteracts TNF-triggered activation of lysosomal cell death pathway. Pretreatment for 1 h with the inhibitors of lysosomal death pathway (A) Baf
A1 (0.05 μM), (B) z-FF-fmk (100 μM), and (C) CA-074-Me (20 μM) reduced TNF-cytotoxicity (TNF at 1 ng/ml for 24 h) in L929 but not in L929-ΔTM-BNIP3. L929-ΔTM-BNIP3 cells were
partly protected by the expression of the dominant-negative mutant of BNIP3. TNF cytotoxicity was assessed byMTTassay. Data represent average values from quadruplicates of four
independent experiments. In control experiment, cells were either treated with TNF solvent (PBS) or with the inhibitors alone at the same concentration as used in the experiments.
(D, E) TNF triggered swelling of lysosomes in L929, but not in L929-ΔTM-BNIP3. L929 (D) and L929-ΔTM-BNIP3 cells (E) were treated with TNF (1 ng/ml for 24 h) in the absence of
actinomycin D and stained with the acidophilic lysosomal probe LysoTracker Red (LTR). TNF caused an increase in volume and frequency of cytoplasmic granule staining with LTR
which was partially inhibited by ΔTM-BNIP3 over-expression (E). Nuclei were visualized by DAPI (blue). In control experiment, cells were treated with PBS. The magniﬁcation
was 1000×. Representative micrographs are shown for all samples.
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molecular mechanisms of BNIP3 actions is very important. It has been
found that both the pro-apoptotic activity of this protein and its
interaction with other members of the Bcl2 family is sensitive to the
presence of its TM segment [57,58]. The functional importance of TM
segment was also conﬁrmed by the fact that the enforced expression
of a BNIP3 mutant lacking this domain partially blocks hypoxia-induced cell death [58]. The results of our study also conﬁrm the
importance of TM domain in BNIP3 induced cell death.
Reactive nitrogen intermediates, including NO, NO2− and NO3−, are
involved in TNF-mediated cytolysis [38] but the mechanism remained
unknown. Here we show that NO intermediates can promote the
transcriptional upregulation of BNIP3. This BNIP3 gene activation is
abolished after treatment with the nitrogen oxide synthase inhibitor
558 S. Ghavami et al. / Biochimica et Biophysica Acta 1793 (2009) 546–560(L-NMMA) in L929. Thus, we concluded that nitric oxide participates
in TNF-induced cytotoxicity by the upregulation of the expression of
BNIP3. The increased level and cellular translocation of BNIP3 from the
nucleus to mitochondria may then trigger mitochondrial dysfunction
frequently observed upon TNF-treatment. L929 cells over-expressing
ΔTM-BNIP3 were partially protected from TNF-induced changes to
Ψm and this coincided with higher residual Ψm in L929-ΔTM-BNIP3
than observed in parental L929 cells. Thus, our ﬁnding provided
further evidence for a role of TNF and BNIP3 in mitochondrial
malfunction as part of the TNF-induced cell death.
Mitchell's chemi-osmotic theory [59] identiﬁedΔΨm as the driving
force for mitochondrial synthesis of ATP, an essential component for
cell viability and the execution of apoptosis. Ψm vary depending on
the physiological status of cells and is increased in activated cells and
tumor cells [60,61]. This suggests that higher Ψm, as observed with
L929-ΔTM-BNIP3 cells, may contribute to increased resistance against
apoptosis. TNF treatment causes a rapid and signiﬁcant ATP depletion
[12,55,62]. The TNF-inducedmitochondrial translocation of BNIP3 and
the subsequent loss of mitochondrial membrane potential may, in
part, explain this effect on cellular ATP levels and stresses the
importance of the TM of BNIP3 for its pro-apoptotic function. By
contrast,ΔTM-BNIP3 over-expression partially attenuated the effect of
TNF on ΔΨm suggesting that this deletion variant may act as a partial
antagonist of BNIP3.
Apoptosis involves the synchronized release [63] with similar
kinetics [64] of cytochrome c, Smac/Diablo, and Omi/HtrA2. This was
also observed in TNF-treated L929 and L929-ΔTM-BNIP3. These
proteins reside in the mitochondrial inter-membrane space whereas
AIF is anchored in the inner membrane [65], and Endo-G likely mainly
localized in the matrix [42]. This would explain the lack of AIF and
Endo-G in TNF-induced cell death in our experimental model.
Insertion of BNIP3 into the mitochondrial outer membrane and
changes inΨmmay participate in the release of Smac/Diablo and Omi/
HtrA2 during TNF-induced cell death. Indirect evidence in support of
this interpretation came from L929 over-expressing ΔTM-BNIP3.
When treated with TNF, these cells showed similar levels of release
for cytochrome c, Smac/Diablo, and Omi/HtrA2 as in L929, emphasiz-
ing the functional importance of the BNIP3 TM domain, and the
inability of ΔTM-BNIP3 to interfere with this release.
Over-expression of ΔTM-BNIP3 counteracted lysosomal damage
during TNF-mediated cell death. Loss of lysosomal integrity with
subsequent activation of cell death cascades has been implicated in
apoptosis during oxidative stress [59,66], growth factor starvation, Fas
activation, α-tocopheryl-succinate-mediated apoptosis in Jurkat T-
cells [60,61], 6-hydroxydopamine-associated death of cultured micro-
glia [67], apoptosis induced by the synthetic retinoid CD437 in human
leukemia HL-60 cells [68], TNF- and bile acid-mediated hepatocyte
apoptosis [69,70], and p53-mediated apoptosis of M1-t-p53 myeloid
leukemic cells [71]. Recently, TNF-cytotoxicity was shown to associate
with the permeabilization of lysosomes, release of cath-B into the
cytosol [72], and subsequent cath-B-induced activation of the
mitochondrial death pathway [69,73]. TNF-mediated apoptosis is
markedly attenuated by alkalinizing acidic vesicles, employing cath-B
inhibitors, or in cath-B knockout mice [73,74]. Furthermore, cath-B
deﬁcient mice are resistant to TNF-mediated liver injury [75]. We
show here that pre-treatment of L929 cells with the vacuolar H+-
ATPase inhibitor baﬁlomycin A1 and the inhibitors of cath-B/cath-L
zFF-fmk and CA-074-Me attenuates the enhanced TNF-mediated cell
death in L929. Moreover, TNF-induced enlargement of lysosomal
volume was inhibited by ΔTM-BNIP3 over-expression and coincided
with decreased levels of ROS in L929-ΔTM-BNIP3 cells. Alterations in
mitochondrial structure and function, as observed with TNF-treated
L929, and subsequent ROS formation seem to be an important step in
TNF cytotoxicity [75]. Inhibition of ROS by pre-treatment with NAC
abolished the increase in lysosomal volume in TNF-exposed L929.
Thus, BNIP3 appears to be involved in the activation of the lysosomalpathway in TNF-mediated cell death. In part, the actions of BNIP3 are
mediated indirectly via increased production of ROS as a result of
ΔΨm. ROS act as locally active messenger and signal mitochondrial
damage to lysosomes which respond by swelling and cathepsin
release, thereby, executing cell death [76].
In conclusion, we show that BNIP3 plays an important role in TNF-
induced cell death. TNF induced an NO-mediated increase in BNIP3
expression and the translocation of BNIP3 to mitochondria, which
resulted in perturbed mitochondrial function and increased ROS
production. Both effects were antagonized by over-expression of
ΔTM-BNIP3 and consequently ΔTM-BNIP3 protected against lysoso-
mal activation in TNF-treated L929 cells. Our data provide a functional
basis and link between BNIP3, a mediator of atypical cell death, and
TNF, known for decades to induce amixed necro-apoptotic form of cell
demise. We used TNF in the absence of the transcriptional inhibitor
actinomycin D, which is frequently employed among TNF-researchers.
This allowed for the detection of TNF-induced changes in gene
expression, which let to our discovery of TNF-induced and NO-
mediated upregulation of BNIP3 as another mechanism contributing
to TNF-induced cell death.
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